Allianz Asset Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,255
| Closed | -$335K | – | 2133 |
|
|
2025
Q1 | $335K | Sell |
5,255
-7,545
| -59% | -$438K | ﹤0.01% | 2003 |
|
|
2024
Q4 | $612K | Sell |
12,800
-1,259
| -9% | -$64.6K | ﹤0.01% | 1791 |
|
|
2024
Q3 | $805K | Buy |
14,059
+7,500
| +114% | +$430K | ﹤0.01% | 1706 |
|
|
2024
Q2 | $343K | Sell |
6,559
-4,000
| -38% | -$175K | ﹤0.01% | 1937 |
|
|
2024
Q1 | $430K | Buy |
+10,559
| New | +$396K | ﹤0.01% | 1667 |
|
|
2023
Q3 | – | Sell |
-23,037
| Closed | -$831K | – | 2218 |
|
|
2023
Q2 | $831K | Sell |
23,037
-610,778
| -96% | -$20.8M | ﹤0.01% | 1599 |
|
|
2023
Q1 | $24.2M | Buy |
633,815
+14,637
| +2% | +$687K | 0.04% | 429 |
|
|
2022
Q4 | $35.2M | Sell |
619,178
-87,100
| -12% | -$4.46M | 0.07% | 304 |
|
|
2022
Q3 | $27.9M | Sell |
706,278
-40,411
| -5% | -$1.79M | 0.06% | 348 |
|
|
2022
Q2 | $32.9M | Buy |
746,689
+134,729
| +22% | +$5.83M | 0.03% | 531 |
|
|
2022
Q1 | $24.4M | Buy |
611,960
+25,686
| +4% | +$915K | 0.02% | 682 |
|
|
2021
Q4 | $23.6M | Buy |
586,274
+25,161
| +4% | +$939K | 0.02% | 713 |
|
|
2021
Q3 | $22.8M | Buy |
561,113
+309,327
| +123% | +$12.9M | 0.02% | 691 |
|
|
2021
Q2 | $11.4M | Buy |
251,786
+217,880
| +643% | +$9.64M | 0.01% | 809 |
|
|
2021
Q1 | $1.41M | Sell |
33,906
-57,522
| -63% | -$2.63M | ﹤0.01% | 1519 |
|
|
2020
Q4 | $3.9M | Buy |
91,428
+14,327
| +19% | +$515K | ﹤0.01% | 1126 |
|
|
2020
Q3 | $2.03M | Sell |
77,101
-48,684
| -39% | -$1.36M | ﹤0.01% | 1261 |
|
|
2020
Q2 | $3.37M | Buy |
125,785
+105,043
| +506% | +$2.37M | ﹤0.01% | 1379 |
|
|
2020
Q1 | $373K | Sell |
20,742
-158,710
| -88% | -$3.01M | ﹤0.01% | 2165 |
|
|
2019
Q4 | $3.18M | Buy |
+179,452
| New | +$3.11M | ﹤0.01% | 1684 |
|
|
2019
Q3 | – | Sell |
-110,968
| Closed | -$1.91M | – | 2755 |
|
|
2019
Q2 | $1.91M | Buy |
110,968
+558
| +0.5% | +$9K | ﹤0.01% | 1902 |
|
|
2019
Q1 | $1.78M | Buy |
+110,410
| New | +$1.79M | ﹤0.01% | 1883 |
|
|
2018
Q4 | – | Sell |
-20,158
| Closed | -$366K | – | 2638 |
|
|
2018
Q3 | $366K | Sell |
20,158
-38,137
| -65% | -$668K | ﹤0.01% | 2450 |
|
|
2018
Q2 | $983K | Hold |
58,295
| – | – | ﹤0.01% | 2239 |
|
|
2018
Q1 | $1.14M | Sell |
58,295
-5,696
| -9% | -$110K | ﹤0.01% | 2161 |
|
|
2017
Q4 | $1.3M | Sell |
63,991
-12,318
| -16% | -$226K | ﹤0.01% | 2156 |
|
|
2017
Q3 | $1.33M | Buy |
76,309
+6,888
| +10% | +$93.3K | ﹤0.01% | 2155 |
|
|
2017
Q2 | $896K | Sell |
69,421
-74,100
| -52% | -$990K | ﹤0.01% | 2257 |
|
|
2017
Q1 | $1.86M | Buy |
143,521
+8,539
| +6% | +$108K | ﹤0.01% | 2023 |
|
|
2016
Q4 | $1.33M | Sell |
134,982
-92,938
| -41% | -$1.02M | ﹤0.01% | 2125 |
|
|
2016
Q3 | $2.73M | Buy |
227,920
+12,031
| +6% | +$123K | ﹤0.01% | 1868 |
|
|
2016
Q2 | $1.86M | Buy |
215,889
+110,520
| +105% | +$1.09M | ﹤0.01% | 1947 |
|
|
2016
Q1 | $998K | Buy |
105,369
+1,324
| +1% | +$12.5K | ﹤0.01% | 2089 |
|
|
2015
Q4 | $1.81M | Sell |
104,045
-8,335
| -7% | -$133K | ﹤0.01% | 1743 |
|
|
2015
Q3 | $1.51M | Buy |
112,380
+8,335
| +8% | +$167K | ﹤0.01% | 1684 |
|
|
2015
Q2 | $2.35M | Buy |
104,045
+15,800
| +18% | +$278K | ﹤0.01% | 1654 |
|
|
2015
Q1 | $1.26M | Buy |
88,245
+11,000
| +14% | +$159K | ﹤0.01% | 1715 |
|
|
2014
Q4 | $745K | Sell |
77,245
-63,000
| -45% | -$560K | ﹤0.01% | 1898 |
|
|
2014
Q3 | $1.28M | Buy |
140,245
+23,000
| +20% | +$219K | ﹤0.01% | 1593 |
|
|
2014
Q2 | $1.16M | Buy |
117,245
+12,000
| +11% | +$102K | ﹤0.01% | 1362 |
|
|
2014
Q1 | $1.34M | Buy |
105,245
+5,000
| +5% | +$74.2K | ﹤0.01% | 1325 |
|
|
2013
Q4 | $1.5M | Sell |
100,245
-15,000
| -13% | -$193K | ﹤0.01% | 1290 |
|
|
2013
Q3 | $1.27M | Buy |
115,245
+34,000
| +42% | +$283K | ﹤0.01% | 1313 |
|
|
2013
Q2 | $646K | Buy |
+81,245
| New | +$517K | ﹤0.01% | 1442 |
|
Other funds holding HALO
SCM
Allianz Asset Management's HALO Position: Q2 2025 in Review
Allianz Asset Management sold out of Halozyme (HALO) in Q2 2025, closing a stake of 5,255 shares — an estimated $335K sold.
Allianz Asset Management first reported a position in HALO in Q2 2013 and held it in 44 quarters. The position peaked at $35.2M in Q4 2022. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.
- Allianz Asset Management reported no remaining Halozyme position as of Q2 2025 after selling out during the quarter.
- Allianz Asset Management sold 5,255 Halozyme shares in Q2 2025, an estimated $335K.
- Allianz Asset Management first reported a position in Halozyme in Q2 2013 and held it in 44 quarters.
- Allianz Asset Management's Halozyme position peaked at $35.2M in Q4 2022.
- 551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.
Based on Allianz Asset Management's 13F filing for Q2 2025, filed 28 Jul 2025.